Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit Melin

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Immunity, Inflammation and Disease|August 30, 2022
Impaired immunity and high attack rates caused by SARS-CoV-2 variants among vaccinated long-term care facility residentsDorothée Obach, Anna Solastie, Oona Liedes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2026
Reduced neutralising antibody responses against emerging 2025/26 influenza A(H1N1)pdm09 subclade D.3.1 and A(H3N2) subclade K viruses among healthcare workers, Finland, August to October 2025Niina Ikonen, Anu Haveri, Erika Lindh, et al.
Open Forum Infectious Diseases|December 15, 2022
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 InfectionNina Ekström, Anu Haveri, Anna Solastie, et al.
Haematologica|March 6, 2025
Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemiaMagdalena Kättström, Bertil Uggla, Camilla Virta, et al.
Frontiers in Immunology|May 9, 2022
Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent PatientsAntti Hurme, Pinja Jalkanen, Jemna Heroum, et al.
Frontiers in Medicine|August 15, 2022
High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020-2021Timothée Dub, Anna Solastie, Lotta Hagberg, et al.
Frontiers in Immunology|February 9, 2023
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine doseMilja Belik, Oona Liedes, Saimi Vara, et al.
Plos One|July 16, 2015
Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) LocusLena Hafrén, Elisabet Einarsdottir, Erna Kentala, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 27, 2020
Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020Anu Haveri, Teemu Smura, Suvi Kuivanen, et al.
Nature Microbiology|December 5, 2025
Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individualsOona Liedes, Arttu Reinholm, Nina Ekström, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Immunity, Inflammation and Disease|August 30, 2022
Impaired immunity and high attack rates caused by SARS-CoV-2 variants among vaccinated long-term care facility residentsDorothée Obach, Anna Solastie, Oona Liedes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2026
Reduced neutralising antibody responses against emerging 2025/26 influenza A(H1N1)pdm09 subclade D.3.1 and A(H3N2) subclade K viruses among healthcare workers, Finland, August to October 2025Niina Ikonen, Anu Haveri, Erika Lindh, et al.
Open Forum Infectious Diseases|December 15, 2022
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 InfectionNina Ekström, Anu Haveri, Anna Solastie, et al.
Haematologica|March 6, 2025
Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemiaMagdalena Kättström, Bertil Uggla, Camilla Virta, et al.
Frontiers in Immunology|May 9, 2022
Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent PatientsAntti Hurme, Pinja Jalkanen, Jemna Heroum, et al.
Frontiers in Medicine|August 15, 2022
High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020-2021Timothée Dub, Anna Solastie, Lotta Hagberg, et al.
Frontiers in Immunology|February 9, 2023
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine doseMilja Belik, Oona Liedes, Saimi Vara, et al.
Plos One|July 16, 2015
Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) LocusLena Hafrén, Elisabet Einarsdottir, Erna Kentala, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 27, 2020
Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020Anu Haveri, Teemu Smura, Suvi Kuivanen, et al.
Nature Microbiology|December 5, 2025
Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individualsOona Liedes, Arttu Reinholm, Nina Ekström, et al.
Pageof 4